Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Jan 11, 2017
Insider Transaction Report
Form 4
Wirth Edward
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2017-01-09−2,056→ 3,415 total - Sale
Common Stock
2017-01-09$4.60/sh−3,415$15,719→ 0 total
Footnotes (2)
- [F1]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,471 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F2]The shares sold were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person.